19:01:39 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for Sept. 3, 2015

2015-09-03 20:46 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 3.70 points to 553.75 Thursday. David Stadnyk's NEX shell, Viper Gold Ltd. (VPR), plans to acquire QuikFlo Technologies Inc., a Calgary health care company.

Viper, which has 5,777,200 shares outstanding, will issue 30 million shares to the shareholders of QuikFlo, after which the shell will change its name to QuikFlo Health Inc. Mr. Stadnyk and fellow Viper director, George Tsafalas, are large shareholders of the shell and its target. Mr. Stadnyk owns 1,535,000 Viper shares and three million QuikFlo shares, while Mr. Tsafalas owns 600,000 Viper shares and 2.7 million QuikFlo shares, making this a non-arm's-length transaction that requires approval from a majority of the shell's minority shareholders, according to TMX policy. The shell has already scheduled a meeting for Oct. 26.

QuikFlo is developing a technology to interpret computerized tomography (CT) scans of stroke patients and provide doctors with specific treatment options. The company says this will decrease the amount of time to diagnose a patient who has suffered a stroke, noting that shorter periods of time between a patient entering a hospital and that patient beginning to receive treatment are strongly correlated with better outcomes for patients. QuikFlo acquired its technology last July from Innovate Calgary, a division of the University of Calgary, which will receive a royalty if this technology makes it past the research and development stage.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed